WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 5 fonti

Can Ozempic Treat Alcoholism? Here's What You Should Know

A recent trial is the latest to suggest that GLP-1s aren't just for treating diabetes and obesity.

Raccontata dagizmodo.comsciencealert.comhindustantimes.comiol.co.zasciencedaily.com

Confronto fonti

5 prospettive sulla stessa storia
AI · summaries
gizmodo.comStai leggendo1 mesi fa

Can Ozempic Treat Alcoholism? Here's What You Should Know

A first Lancet RCT (26 weeks, n=100) found semaglutide reduced alcohol consumption and heavy drinking days vs placebo. The shared dopamine mechanism implies GLP-1s could address multiple addictions, reshaping Novo Nordisk's pipeline beyond obesity.

originale
sciencedaily.com1 mesi fa

Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose

GLP-1 drugs reduce substance use disorder risk 14-25% and overdose mortality 50%, per 606k-veteran study validating broader therapeutic applications in addiction. Existing GLP-1 drugs may unlock addiction treatment via shared craving biology, shortcutting drug development cycles without new compound discovery.

Leggi questa versione → originale
hindustantimes.com1 mesi fa

Less stress, addiction, brain fog: Ozempic, GLP-1 drugs may be impacting patients' brain, neural networks

GLP-1 drugs may curb addiction and craving, making some patients less likely to drink alcohol. It could ease anxiety, compulsive thinking and emotional distress | World News

Leggi questa versione → originale
sciencealert.com1 mesi fa

Weight Loss on GLP-1 Drugs Linked to Lower Risk of Disease, Study Finds

Does losing weight by taking GLP-1 drugs such as Ozempic and Wegovy actually improve your risk of other diseases associated with obesity? New research led by scientists at the University of Liverpool in the UK, and…

Leggi questa versione → originale
iol.co.za1 mesi fa

The good, bad and ugly of GLP-1 weight-loss drugs: Ozempic scams, celebrity hype and nasty side effects

From dramatic weight loss to dangerous side effects and fake Ozempic scams, here’s the truth about the GLP-1 craze gripping South Africa and Hollywood.

Leggi questa versione → originale

Timeline cronologica

  1. martedì 26 maggio 2026·gizmodo.com

    Ozempic Is Finally Turning the Tide Against Obesity, New Data Shows

    As the rate of GLP-1 prescriptions in the U.S. has risen, the obesity rate has dropped.

  2. giovedì 28 maggio 2026·sciencealert.com

    One Weight Loss Strategy Is 5x More Effective Than Ozempic, Study Shows

    Ozempic and other semaglutide medications have been working wonders in terms of shedding pounds for many people.

  3. giovedì 28 maggio 2026·sciencealert.com

    Weight Loss on GLP-1 Drugs Linked to Lower Risk of Disease, Study Finds

    Does losing weight by taking GLP-1 drugs such as Ozempic and Wegovy actually improve your risk of other diseases associated with obesity? New research led by scientists at the…

  4. venerdì 29 maggio 2026·gizmodo.com

    Can Ozempic Treat Alcoholism? Here's What You Should Know

    A recent trial is the latest to suggest that GLP-1s aren't just for treating diabetes and obesity.

  5. sabato 30 maggio 2026·hindustantimes.com

    Less stress, addiction, brain fog: Ozempic, GLP-1 drugs may be impacting patients' brain, neural networks

    GLP-1 drugs may curb addiction and craving, making some patients less likely to drink alcohol. It could ease anxiety, compulsive thinking and emotional distress | World News

  6. domenica 31 maggio 2026·iol.co.za

    The good, bad and ugly of GLP-1 weight-loss drugs: Ozempic scams, celebrity hype and nasty side effects

    From dramatic weight loss to dangerous side effects and fake Ozempic scams, here’s the truth about the GLP-1 craze gripping South Africa and Hollywood.

  7. lunedì 1 giugno 2026·sciencedaily.com

    Most people who stop GLP-1 drugs like Ozempic eventually return

    Many people prescribed GLP-1 drugs for type 2 diabetes (such as Victoza, Ozempic, or tirzepatide) stop taking them, but a surprising number later return to treatment. Researchers…

  8. lunedì 1 giugno 2026·sciencedaily.com

    Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose

    A massive study of more than 600,000 U.S. veterans suggests that popular GLP-1 drugs such as semaglutide may do far more than help with diabetes and weight loss—they could also…

  9. lunedì 1 giugno 2026·sciencedaily.com

    Ozempic changed obesity treatment, but experts say the real revolution is next

    The obesity treatment landscape is changing fast, with GLP-1 drugs opening the door to more effective care than ever before. Experts now envision a future where medications,…

  10. lunedì 1 giugno 2026·sciencedaily.com

    Ozempic and Wegovy linked to surprising drop in violent behavior

    A Rutgers study suggests GLP-1 drugs such as Ozempic and Wegovy may weaken the link between impulsive tendencies and violent behavior. The surprising finding hints that these…

  11. lunedì 1 giugno 2026·sciencedaily.com

    Scientists discover why ozempic may not work for some people

    Scientists have identified genetic variants that may make some people less responsive to GLP-1 drugs used to treat Type 2 diabetes. Roughly 10% of the population carries these…